| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |